Is Greenwich Lifesciences Inc (GLSI) overvalued? · $144.9M cap
Greenwich Lifesciences Inc (GLSI) is a biotechnology company listed on US.
This page asks whether Greenwich Lifesciences Inc (GLSI) looks expensive on cached numbers — not a short thesis.
No cached income statement for GLSI, so there is no earnings base to call rich or cheap.
GLSI currently screens at market cap $144.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GLSI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GLSI stock page for the full model, not this heading.
Not investment advice.